// App-Quantinova.ai

1239 : NVP-HDM201: Biochemical and biophysical profile of a novel highly potent and selective PPI inhibitor of p53-Mdm2

Researchers

Presenter

  • Therese Stachyra-Valat

Principal Investigators

  • Frederic Baysang

  • Anne-Cecile DAlessandro

  • Erdmann Dirk

  • Pascal Furet

  • Vito Guagnano

  • Joerg Kallen

  • Lukas Leder

  • Robert Mah

  • Keiichi Masuya

  • Stefan Stutz

  • Andrea Vaupel

  • Francesco Hofmann

  • Patrick Chene

  • Sebastien Jeay

  • Philipp Holzer

Medical Centers

  • Novartis Institutes for BioMedical Research, Basel, Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • HDM 201

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved